Skip to Main Content

Paper Details

A Low-Frequency Inactivating <i>AKT2</i> Variant Enriched in the Finnish Population Is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk.
Diabetes
38
2017
AKT2, AKT2 Variant, FI, FI-increasing allele, Insulin, Pro50Thr, Thr50, Type 2 Diabetes, exome array, exome sequence, frequency allele, glucose, insulin, low-, monogenic glycemic disorders, normoglycemic, pleckstrin homology domain, type 2 diabetes
Author NameAffiliation
Alisa K ManningBroad Institute
Alisa K ManningHarvard Medical School
Alisa K ManningCenter for Human Genetic Research, Massachusetts General Hospital
Heather M HighlandThe University of Texas MD Anderson Cancer Center and The University of Texas Health Science Center at Houston Graduate School of Biomedical Sciences
Heather M HighlandThe University of North Carolina at Chapel Hill
Jessica A GasserBroad Institute
Xueling SimDepartment of Biostatistics and Center for Statistical Genetics, School of Public Health, University of Michigan ann arbor
Xueling SimSaw Swee Hock School of Public Health, National University of Singapore
Taru TukiainenBroad Institute
Taru TukiainenHarvard Medical School
Taru TukiainenMassachusetts General Hospital
Pierre FontanillasBroad Institute
Pierre Fontanillas
Niels GrarupThe Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Manuel A RivasUniversity of Oxford
Manuel A RivasUniversity of Oxford
Anubha MahajanUniversity of Oxford
Adam E LockeDepartment of Biostatistics and Center for Statistical Genetics, School of Public Health, University of Michigan ann arbor
Pablo CingolaniMcGill University
Pablo CingolaniMcGill University and Genome Quebec Innovation Centre
Tune H PersBroad Institute
Tune H PersStatens Serum Institut
Tune H PersDivisions of Endocrinology and Genetics and Genomics and Center for Basic and Translational Obesity Research, Boston Children's Hospital
Tune H PersThe Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Ana ViñuelaKing's College London
Ana ViñuelaInstitute of Genetics and Genomics in Geneva, University of Geneva
Ana ViñuelaUniversity of Geneva Medical School
Andrew A BrownWellcome Trust Sanger Institute
Andrew A BrownNorwegian Centre for Mental Disorders Research and KG Jebsen Center for Psychosis Research, Oslo University Hospital
Ying WuThe University of North Carolina at Chapel Hill
Jason FlannickBroad Institute
Jason FlannickMassachusetts General Hospital
Christian FuchsbergerDepartment of Biostatistics and Center for Statistical Genetics, School of Public Health, University of Michigan ann arbor
Eric R GamazonThe University of Chicago
Eric R GamazonAcademic Medical Center, University of Amsterdam
Eric R GamazonThe University of Chicago
Eric R GamazonAcademic Medical Center, University of Amsterdam
Kyle J GaultonUniversity of Oxford
Kyle J GaultonUniversity of California
Hae Kyung ImThe University of Chicago
Tanya M TeslovichDepartment of Biostatistics and Center for Statistical Genetics, School of Public Health, University of Michigan ann arbor
Thomas W BlackwellDepartment of Biostatistics and Center for Statistical Genetics, School of Public Health, University of Michigan ann arbor
Jette Bork-JensenThe Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Noel BurttBroad Institute
Yuhui ChenUniversity of Oxford
Todd GreenBroad Institute
Christopher HartlBroad Institute
Hyun Min KangDepartment of Biostatistics and Center for Statistical Genetics, School of Public Health, University of Michigan ann arbor
Ashish KumarUniversity of Oxford
Ashish KumarSwiss Tropical and Public Health Institute, University of Basel
  • 1 - 50

Datasets